Metal–organic frameworks (MOFs) have garnered attention in clinical sensing applications
due to their tailored structural and electronic properties, which facilitate the development of …

Abstract Programmed death receptor-1 (PD-1) and its ligand, programmed death ligand-1
(PD-L1) are essential molecules that are key in modulating immune responses. PD-L1 is …

Surgical intervention followed by chemotherapy is the principal treatment strategy for
bladder cancer, which is hindered by significant surgical risks, toxicity from chemotherapy …

Bladder cancer is a common urological cancer with a high recurrence rate that requires long‐
term follow‐up, and early detection positively affects prognosis. To date, the initial diagnosis …

Urine-based testing is promising for noninvasive diagnosis of urothelial carcinoma (UC) but
has suboptimal sensitivity for early-stage tumors. Herein, we developed a multitarget urine …

Bladder cancer is the tenth most common cancer and is a significant burden on health care
services worldwide, as it is one of the most costly cancers to treat per patient. This expense …

Gestational diabetes mellitus (GDM) is one of the most common metabolic complications
during pregnancy, threatening both maternal and fetal health. Prediction and diagnosis of …

Synthetic Notch (synNotch) receptors have enabled mammalian cells to sense extracellular
ligands and respond by activating user-prescribed transcriptional programs. Based on the …

Bladder cancer is the 10th most common cancer and the 9th cause of death by malignancy
worldwide. Invasiveness and morbidity of cystoscopy, relatively low sensitivity of urinary …

Background and objective While collagen density has been associated with poor outcomes
in various cancers, its role in prostate cancer (PCa) remains elusive. Our aim was to analyze …